GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silver Spike Investment Corp (NAS:SSIC) » Definitions » Other Net Income (Loss)

Silver Spike Investment (Silver Spike Investment) Other Net Income (Loss) : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Silver Spike Investment Other Net Income (Loss)?

Silver Spike Investment's Other Net Income (Loss) for the three months ended in Mar. 2024 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.


Silver Spike Investment Other Net Income (Loss) Historical Data

The historical data trend for Silver Spike Investment's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silver Spike Investment Other Net Income (Loss) Chart

Silver Spike Investment Annual Data
Trend Mar21 Mar22 Dec23
Other Net Income (Loss)
- - -

Silver Spike Investment Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Silver Spike Investment Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Silver Spike Investment Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Silver Spike Investment's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Silver Spike Investment (Silver Spike Investment) Business Description

Traded in Other Exchanges
N/A
Address
600 Madison Avenue, Suite 1800, New York, NY, USA, 10022
Silver Spike Investment Corp is a closed-end management investment company formed to invest in companies across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately-held cannabis businesses.
Executives
Umesh Mahajan officer: Chief Financial Officer 600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Scott Gordon director, 10 percent owner, officer: Chief Executive Officer 1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Gregory M. Gentile 10 percent owner, officer: CFO, CCO & Sec. 1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Silver Spike Capital, Llc 10 percent owner 600 MADISON AVE, SUITE 1800, NEW YORK NY 10022
Warson Tracey Brophy director 1350 AVENUE OF THE AMERICAS, NEW YORK NY 10019
Silver Spike Holdings, Lp 10 percent owner 600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Michael William Chorske director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Vivek Bunty Bohra director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Silver Spike Holdings Gp, Llc 10 percent owner 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Da Corte Americo director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065